Latest filing published 11 Oct 2018 for Spectrum Pharmaceuticals INC, €133k.
Filing timeline
BuySaleInsider track record
Gilles Gagnon: trading record in brief
Gilles Gagnon appears in our data through filings on Spectrum Pharmaceuticals Inc shares, published by SEC (Form 4). We count 8 filings; the first trade dates from 19 December 2012 and the latest from 9 October 2018.
The open-market record consists of 1 sale worth €133k, with no purchase. Besides market trades, the filings include 7 share grants. Since January 2018: no purchases and 1 sale on the market.
The latest filing, published on 11 October 2018, reports an open-market sale of €133k in Spectrum Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gilles Gagnon
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$15.33100.0% of flowCommon Stock, $0.001 par valueSEC:0001209191-18-054844:0
- 10,000 shares0Common Stock, $0.001 par valueSEC:0001209191-18-038684:0
- 2,500 shares@ US$6.489.8% of flowCommon Stock, $0.001 par valueSEC:0001209191-17-040170:0
- 10,000 shares0Common Stock, $0.001 par valueSEC:0001209191-17-040170:1
- 10,000 shares0Common Stock, $0.001 par valueSEC:0001209191-15-058296:0
- 10,000 shares0Common Stock, $0.001 par valueSEC:0001209191-14-044850:0
- 10,000 shares0Common Stock, $0.001 par valueSEC:0001209191-13-057422:0
7 of 7 declarations